Stonebridge Capital Advisors LLC increased its stake in shares of Colgate-Palmolive (NYSE:CL) by 20.6% during the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 4,280 shares of the company’s stock after buying an additional 730 shares during the quarter. Stonebridge Capital Advisors LLC’s holdings in Colgate-Palmolive were worth $317,000 at the end of the most recent reporting period.
A number of other institutional investors also recently made changes to their positions in CL. Transamerica Financial Advisors Inc. raised its position in Colgate-Palmolive by 0.3% in the first quarter. Transamerica Financial Advisors Inc. now owns 25,183 shares of the company’s stock valued at $1,844,000 after purchasing an additional 67 shares during the period. Ronald Blue & Co. LLC raised its position in Colgate-Palmolive by 1.1% in the first quarter. Ronald Blue & Co. LLC now owns 3,501 shares of the company’s stock valued at $256,000 after purchasing an additional 37 shares during the period. USS Investment Management Ltd raised its position in Colgate-Palmolive by 1.6% in the first quarter. USS Investment Management Ltd now owns 683,600 shares of the company’s stock valued at $50,036,000 after purchasing an additional 10,600 shares during the period. Stifel Financial Corp grew its stake in shares of Colgate-Palmolive by 0.8% in the first quarter. Stifel Financial Corp now owns 303,934 shares of the company’s stock valued at $22,250,000 after buying an additional 2,360 shares in the last quarter. Finally, ARS Investment Partners LLC grew its stake in shares of Colgate-Palmolive by 0.5% in the first quarter. ARS Investment Partners LLC now owns 35,531 shares of the company’s stock valued at $2,601,000 after buying an additional 175 shares in the last quarter. Hedge funds and other institutional investors own 72.96% of the company’s stock.
In other news, COO Justin Skala sold 126,393 shares of the business’s stock in a transaction dated Thursday, November 9th. The stock was sold at an average price of $72.97, for a total value of $9,222,897.21. Following the completion of the sale, the chief operating officer now directly owns 262,361 shares of the company’s stock, valued at approximately $19,144,482.17. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Victoria L. Dolan sold 10,000 shares of the business’s stock in a transaction dated Thursday, November 9th. The shares were sold at an average price of $73.07, for a total value of $730,700.00. Following the completion of the sale, the insider now directly owns 60,528 shares of the company’s stock, valued at $4,422,780.96. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 173,673 shares of company stock valued at $12,629,293. Insiders own 1.02% of the company’s stock.
Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, October 27th. The company reported $0.73 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.73. The business had revenue of $3.97 billion during the quarter, compared to analysts’ expectations of $3.94 billion. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. The business’s quarterly revenue was up 2.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.73 EPS. equities research analysts anticipate that Colgate-Palmolive will post 2.88 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, November 15th. Stockholders of record on Monday, October 23rd were given a dividend of $0.40 per share. The ex-dividend date of this dividend was Friday, October 20th. This represents a $1.60 annualized dividend and a dividend yield of 2.15%. Colgate-Palmolive’s dividend payout ratio is currently 61.78%.
CL has been the subject of a number of research reports. Zacks Investment Research cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Tuesday, September 26th. Jefferies Group reaffirmed a “hold” rating and issued a $79.00 price objective on shares of Colgate-Palmolive in a research note on Thursday, September 28th. Morgan Stanley dropped their price objective on Colgate-Palmolive from $84.00 to $83.00 and set an “overweight” rating for the company in a research note on Tuesday, October 31st. KeyCorp reaffirmed a “hold” rating on shares of Colgate-Palmolive in a research note on Monday, October 16th. Finally, Macquarie assumed coverage on Colgate-Palmolive in a research note on Thursday, September 14th. They set a “neutral” rating and a $76.00 target price for the company. Two equities research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and four have assigned a buy rating to the company’s stock. Colgate-Palmolive has an average rating of “Hold” and an average target price of $76.04.
COPYRIGHT VIOLATION NOTICE: This report was originally posted by Ticker Report and is owned by of Ticker Report. If you are viewing this report on another publication, it was illegally copied and republished in violation of U.S. and international trademark and copyright laws. The original version of this report can be accessed at https://www.tickerreport.com/banking-finance/3079721/stonebridge-capital-advisors-llc-has-317000-position-in-colgate-palmolive-cl.html.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.